cellulitis

Search with Google Search with Bing
Information
Disease name
cellulitis
Disease ID
DOID:3488
Description
"A skin disease where there is a diffuse infection of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin. Cellulitis can be caused by normal skin flora or by exogenous bacteria, and often occurs where the skin has previously been broken: cracks in the skin, cuts, blisters, burns, insect bites, surgical wounds, or sites of intravenous catheter insertion." [url:http\://en.wikipedia.org/wiki/Cellulitis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03785834 Active, not recruiting The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis May 25, 2018 December 31, 2025
NCT05226260 Active, not recruiting N/A Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care November 1, 2021 March 1, 2024
NCT01706913 Active, not recruiting N/A Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis October 2012 December 31, 2025
NCT00289588 Completed N/A An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers January 2005 December 2005
NCT00295178 Completed Phase 4 Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas February 20, 2006 August 9, 2006
NCT00514527 Completed Phase 2 A Study for Patients With Complicated Skin and Skin Structure Infections August 2007 May 2008
NCT00619710 Completed Phase 3 Complicated Skin and Skin Structure Infections February 2001 April 2004
NCT00636025 Completed Cellulite and Magnetic Resonance Imaging July 2008 December 2010
NCT00676130 Completed N/A Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients May 2007 May 2012
NCT00714402 Completed Procalcitonin Level and Kinetics in Children With Bacterial Infections August 2008
NCT00737269 Completed A Complicated Skin and Soft-tissue Infection Patient Registry June 2008 January 2010
NCT00746109 Completed Phase 4 Study of Wound Packing After Superficial Skin Abscess Drainage September 2008 March 2010
NCT00984022 Completed Phase 2 Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage March 2008 February 23, 2010
NCT01029782 Completed Phase 2 Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis May 2010 October 2014
NCT01085929 Completed Phase 3 Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses August 2008 December 2009
NCT05959928 Completed Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture February 9, 2021 June 2, 2021
NCT00139100 Completed N/A Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area February 2001 March 2002
NCT00257036 Completed Phase 2/Phase 3 A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin July 1991 February 1993
NCT02334124 Completed N/A Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital January 2015 November 2022
NCT02864420 Completed N/A Hospitalization at Home: The Acute Care Home Hospital Program for Adults September 2016 December 2016
NCT03034694 Completed N/A The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting January 2016 January 2018
NCT03036358 Completed N/A Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting January 2016 January 2018
NCT03275259 Completed N/A Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat April 3, 2017 December 1, 2018
NCT03296280 Completed Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program October 3, 2016 September 30, 2020
NCT03474523 Completed N/A Effectiveness of Diathermy-Radiofrecuency Compared With Cavitation in Cellulitis Treatment October 20, 2017 March 11, 2020
NCT03556917 Completed Phase 2/Phase 3 The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. June 14, 2018 April 4, 2019
NCT03846635 Completed Handheld Infrared Thermometer to Evaluate Cellulitis August 28, 2018 January 31, 2020
NCT04091672 Completed N/A RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction March 2, 2020 February 2, 2023
NCT04393909 Completed N/A Improving Safety of Diagnosis and Therapy in the Inpatient Setting July 1, 2019 December 30, 2021
NCT04471246 Completed Phase 4 High-dose vs. Standard-dose Cephalexin for Cellulitis August 16, 2021 February 23, 2022
NCT04928235 Completed Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency Department July 18, 2021 February 18, 2023
NCT05023200 Completed The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study June 9, 2021 September 2, 2023
NCT05624216 Completed N/A Radiofrequency and Targeted Pressure Energy for Cellulite Reduction July 30, 2019 October 25, 2021
NCT00061633 Completed Phase 2 Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) June 2003 January 2004
NCT01252719 Completed Phase 3 Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I) December 2010 November 30, 2012
NCT01252732 Completed Phase 3 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection December 2010 June 2013
NCT01339091 Completed Phase 3 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections March 2011 November 2012
NCT01431339 Completed Phase 3 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections July 2011 December 2012
NCT01519492 Completed Phase 2 A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci February 2012 August 2012
NCT01519778 Completed Phase 2 A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study February 15, 2012 August 27, 2012
NCT01549613 Completed Phase 4 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections May 2012 July 2013
NCT01557426 Completed Phase 1 Soft Tissue Ultrasound of Infections March 2012 March 2015
NCT01626560 Completed Phase 4 The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin July 2012 March 2015
NCT01671423 Completed N/A Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis August 2012 September 2015
NCT01795092 Completed N/A A Study Assessing the Impact of Dermatology Consultation in Patients Presenting With Possible Cellulitis February 2012 December 2012
NCT01876628 Completed Phase 4 Adjunctive Clindamycin for Cellulitis: C4C Trial. October 2013 March 2016
NCT01974115 Completed N/A Extracorporeal Shock Wave Treatment for Cellulite December 2008 July 2011
NCT02024282 Completed N/A Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care January 2013 December 2014
NCT02127970 Completed Phase 3 Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections April 18, 2014 March 11, 2015
NCT02230813 Completed Predictors of Oral Antibiotic Treatment Failure in Emergency Department Patients With Cellulitis March 2015 September 27, 2016
NCT05852262 Enrolling by invitation Phase 4 High-dose Cephalexin for Cellulitis (HI-DOCC) August 30, 2023 August 1, 2026
NCT01238276 No longer available Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
NCT05473325 Not yet recruiting Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) January 1, 2023 June 22, 2025
NCT02032654 Terminated Phase 4 Duration of ANtibiotic Therapy for CEllulitis August 26, 2014 September 25, 2017
NCT03619746 Terminated N/A Point-of-Care Ultrasound Educational Initiative for Insect Bites August 10, 2018 June 30, 2020
NCT02087527 Terminated N/A Use of Corticosteroids in Children With Cellulitis June 2014 March 2016
NCT01773499 Terminated Sonographic Features of Cellulitis and Failure of Therapy January 2013 October 2014
NCT01947660 Unknown status N/A Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery October 2013 November 2015
NCT02922686 Unknown status Phase 4 Penicillin for the Emergency Department Outpatient Treatment of CELLulitis December 2016 December 2019
NCT00489021 Unknown status N/A Feasibility and Outcomes of Older Patients Hospitalization July 2007 August 2007
NCT01429428 Unknown status N/A Far-IR Emitted by Compression Stockings for Cellulitis Treatment July 2011 March 2012
NCT03312946 Unknown status N/A Effect of Vibro-oscillatory Therapy for Improvement of Body Contour and Appearance of Cellulite. October 13, 2017 February 4, 2018
NCT00323219 Unknown status Phase 3 Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department January 2004 December 2013
NCT03917134 Unknown status N/A Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy May 1, 2019 January 30, 2020
NCT03781024 Unknown status A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care December 1, 2018 June 1, 2022
NCT00893048 Withdrawn Phase 2 The Use of Oral Steroids in the Treatment of Cellulitis January 15, 2010 August 31, 2010
Disase is a (Disease Ontology)
DOID:37
Cross Reference ID (Disease Ontology)
ICD10CM:L03.90
Cross Reference ID (Disease Ontology)
MESH:D002481
Cross Reference ID (Disease Ontology)
NCI:C26715
Cross Reference ID (Disease Ontology)
NCI:C34454
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:267833003
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:74276003
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0007642
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0007646
HPO alt_id (Human Phenotype Ontology)
HP:0003553
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0100658
MedGen concept unique identifier (MedGen Concept name)
C0162627
MedGen unique identifier (MedGen Concept name)
56470
ICD10 preferred id (Insert disease from ICD10)
D0009630
ICD10 class code (Insert disease from ICD10)
L03
MeSH unique ID (MeSH (Medical Subject Headings))
D002481